A client receives ondansetron prior to a chemotherapy treatment. How should the practical nurse evaluate the effectiveness of the medication?

A. Monitor the client for nausea or vomiting following the treatment: Ondansetron is an antiemetic used to prevent or reduce chemotherapy-induced nausea and vomiting. Evaluating its effectiveness involves assessing whether the client experiences these specific symptoms during and after treatment. B. Observe the client for signs of pain or discomfort during the treatment: While monitoring for pain is important, ondansetron does not address pain. Observing pain does not provide information about the effectiveness of this antiemetic. C. Assess for changes in vital signs during and after the treatment: Vital signs may be influenced by chemotherapy or other medications, but they are not a reliable measure of ondansetron’s effectiveness in controlling nausea and vomiting. D. Determine if the client feels calm and relaxed before the treatment: Ondansetron does not have anxiolytic properties. Evaluating the client’s emotional state before treatment does not assess the effectiveness of the medication in preventing nausea or vomiting.